Stock chart
Ticker: BBIO Exchange: NSM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale
Past 90 days
 
Value bought
 
Value sold
 
Net insiders buying
 
Trades (buy and sell)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Total value Details
2024-03-05 2024-03-01 PS Planned sale

Scott Randal W.

Non-Executive Director
2,500 -27.8%
34.00
85,000 USD
2,500 -27.8% 34.00 85,000 USD
2024-02-20 2024-02-15 PS Planned sale

Valantine Hannah

Non-Executive Director
2,915 -62.3%
37.75
110,041 USD
2,915 -62.3% 37.75 110,041 USD
2024-01-18 2024-01-16 PS Planned sale

Valantine Hannah

Non-Executive Director
2,915 -62.3%
37.97
110,683 USD
2,915 -62.3% 37.97 110,683 USD
2023-12-28 2023-12-26 PS Planned sale

MCCORMICK FRANK

Non-Executive Director
100,000 -13.7%
42.06
4,206,000 USD
100,000 -13.7% 42.06 4,206,000 USD
2023-12-20 2023-12-18 PS Planned sale

Scott Randal W.

Non-Executive Director
2,000 -18.2%
40.00
80,000 USD
2,000 -18.2% 40.00 80,000 USD
2023-12-19 2023-12-15 PS Planned sale

Valantine Hannah

Non-Executive Director
2,915 -62.3%
36.12
105,290 USD
2,915 -62.3% 36.12 105,290 USD
2023-12-05 2023-12-01 PS Planned sale

Scott Randal W.

Non-Executive Director
1,500 -12.0%
30.00
45,000 USD
1,500 -12.0% 30.00 45,000 USD
2023-12-05 2023-12-01 PS Planned sale

Scott Randal W.

Non-Executive Director
1,000 -7.4%
28.50
28,500 USD
1,000 -7.4% 28.50 28,500 USD
2023-11-20 2023-11-17 PS Planned sale

Kumar Neil

CEO and President

Executive Director
200 -0.0%
29.55
5,910 USD
200 -0.0% 29.55 5,910 USD
2023-11-20 2023-11-17 PS Planned sale

Kumar Neil

CEO and President

Executive Director
51,352 -1.1%
29.10
1,494,128 USD
51,352 -1.1% 29.10 1,494,128 USD
2023-11-20 2023-11-17 PS Planned sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
22,685 -38.2%
29.10
660,059 USD
22,685 -38.2% 29.10 660,059 USD
2023-11-17 2023-11-15 PS Planned sale

Valantine Hannah

Non-Executive Director
2,915 -62.3%
30.00
87,450 USD
2,915 -62.3% 30.00 87,450 USD
2023-09-07 2023-09-05 PS Planned sale

Scott Randal W.

Non-Executive Director
2,500 -15.6%
30.00
75,000 USD
2,500 -15.6% 30.00 75,000 USD
2023-08-18 2023-08-17 PS Planned sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
22,683 -38.2%
28.59
648,455 USD
22,683 -38.2% 28.59 648,455 USD
2023-08-18 2023-08-17 PS Planned sale

Kumar Neil

CEO and President

Executive Director
51,552 -1.1%
28.59
1,473,784 USD
51,552 -1.1% 28.59 1,473,784 USD
2023-07-19 2023-07-18 S Sale

VIKING GLOBAL INVESTORS LP

Major owner
1,500,000 -5.6%
35.00
52,500,000 USD
1,500,000 -5.6% 35.00 52,500,000 USD
2023-05-18 2023-05-17 PS Planned sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
24,424 -40.1%
14.01
342,168 USD
24,424 -40.1% 14.01 342,168 USD
2023-05-18 2023-05-17 PS Planned sale

Kumar Neil

CEO and President

Executive Director
51,552 -1.1%
14.01
722,218 USD
51,552 -1.1% 14.01 722,218 USD
2023-05-05 2023-05-03 PS Planned sale

Kumar Neil

CEO and President

Executive Director
120,000 -10.6%
14.18
1,701,744 USD
120,000 -10.6% 14.18 1,701,744 USD
2023-05-05 2023-05-03 PS Planned sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
64,929 -64.1%
14.18
920,693 USD
64,929 -64.1% 14.18 920,693 USD
2023-04-07 2023-04-05 PS Planned sale

Kumar Neil

CEO and President

Executive Director
120,000 -9.6%
15.46
1,855,656 USD
120,000 -9.6% 15.46 1,855,656 USD
2023-04-07 2023-04-05 PS Planned sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
55,500 -35.4%
15.45
857,697 USD
55,500 -35.4% 15.45 857,697 USD
2023-03-03 2023-03-03 PS Planned sale

Kumar Neil

CEO and President

Executive Director
120,000 -8.7%
10.96
1,315,224 USD
120,000 -8.7% 10.96 1,315,224 USD
2023-03-03 2023-03-03 PS Planned sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
62,692 -28.6%
10.96
687,148 USD
62,692 -28.6% 10.96 687,148 USD
2023-02-21 2023-02-17 PS Planned sale

Kumar Neil

CEO and President

Executive Director
44,798 -0.9%
12.70
569,073 USD
44,798 -0.9% 12.70 569,073 USD
2023-02-21 2023-02-17 PS Planned sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
2,150 -1.0%
13.06
28,089 USD
2,150 -1.0% 13.06 28,089 USD
2023-02-21 2023-02-17 PS Planned sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
15,567 -6.6%
12.65
196,977 USD
15,567 -6.6% 12.65 196,977 USD
2023-02-06 2023-02-03 PS Planned sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
61,040 -21.8%
11.01
671,922 USD
61,040 -21.8% 11.01 671,922 USD
2023-02-06 2023-02-03 PS Planned sale

Kumar Neil

CEO and President

Executive Director
120,000 -8.0%
11.01
1,320,696 USD
120,000 -8.0% 11.01 1,320,696 USD
2023-01-06 2023-01-05 PS Planned sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
61,040 -17.9%
7.67
468,470 USD
61,040 -17.9% 7.67 468,470 USD
2023-01-06 2023-01-05 PS Planned sale

Kumar Neil

CEO and President

Executive Director
120,000 -7.4%
7.67
920,856 USD
120,000 -7.4% 7.67 920,856 USD
2022-12-21 2022-12-21 S Sale

Kumar Neil

CEO and President

Executive Director
200,000
0.00
0 USD
200,000 0.00 0 USD
2022-11-18 2022-11-17 S Sale

Kumar Neil

CEO and President

Executive Director
34,640 -0.7%
9.40
325,606 USD
34,640 -0.7% 9.40 325,606 USD
2022-11-18 2022-11-17 S Sale

STEPHENSON BRIAN C

Secretary, Treasurer & CFO

Officer
19,678 -5.5%
9.40
184,985 USD
19,678 -5.5% 9.40 184,985 USD
2022-03-17 2022-03-15 B Purchase

Ellis Andrea

Non-Executive Director
12,000 +inf%
8.39
100,680 USD
12,000 +inf% 8.39 100,680 USD
2022-03-16 2022-03-14 B Purchase

Dachille Douglas A.

Non-Executive Director
10,000 +100.0%
8.19
81,934 USD
10,000 +100.0% 8.19 81,934 USD
2022-01-06 2022-01-05 B Purchase

Dachille Douglas A.

Non-Executive Director
5,000 +100.0%
15.91
79,550 USD
5,000 +100.0% 15.91 79,550 USD
2022-01-06 2022-01-04 B Purchase

Dachille Douglas A.

Non-Executive Director
5,000 +inf%
16.82
84,100 USD
5,000 +inf% 16.82 84,100 USD
2022-01-03 2021-12-30 B Purchase

Lo Andrew

Non-Executive Director
1,500 +3.2%
14.30
21,450 USD
1,500 +3.2% 14.30 21,450 USD
2022-01-03 2021-12-29 B Purchase

MOMTAZEE JAMES C

Non-Executive Director
80,000 +942.2%
14.50
1,160,000 USD
80,000 +942.2% 14.50 1,160,000 USD
2022-01-03 2021-12-29 B Purchase

Lo Andrew

Non-Executive Director
6,000 +14.8%
12.90
77,400 USD
6,000 +14.8% 12.90 77,400 USD
2022-01-03 2021-12-29 B Purchase

Hassan Fred

Non-Executive Director
19,300 +inf%
14.17
273,390 USD
19,300 +inf% 14.17 273,390 USD
2022-01-03 2021-12-29 B Purchase

Valantine Hannah

Non-Executive Director
1,764 +inf%
14.23
25,102 USD
1,764 +inf% 14.23 25,102 USD
2022-01-03 2021-12-29 B Purchase

SAUNDERS BRENT L

Non-Executive Director
17,600 +inf%
14.48
254,880 USD
17,600 +inf% 14.48 254,880 USD
2024-02-13 2021-12-28 B Purchase

Valantine Hannah

Non-Executive Director
1,542 +81.5%
12.68
19,553 USD
1,542 +81.5% 12.68 19,553 USD
2024-02-13 2021-12-28 B Purchase

Valantine Hannah

Non-Executive Director
1,891 +inf%
13.18
24,923 USD
1,891 +inf% 13.18 24,923 USD
2021-02-18 2021-02-17 B Purchase

STEPHENSON BRIAN C

See Remarks

Officer
8,000 +2.7%
62.50
500,000 USD
8,000 +2.7% 62.50 500,000 USD
2021-02-18 2021-02-17 B Purchase

Scott Randal W.

Non-Executive Director
16,000 +320.0%
62.50
1,000,000 USD
16,000 +320.0% 62.50 1,000,000 USD
2021-02-17 2021-02-17 S Sale

KKR Genetic Disorder L.P.

Major owner
3,450,000 -10.0%
60.47
208,617,360 USD
3,450,000 -10.0% 60.47 208,617,360 USD
2020-12-29 2020-12-28 PS Planned sale

Turtle Cameron

See Remarks

Officer
8,563 -40.5%
69.94
598,855 USD
8,563 -40.5% 69.94 598,855 USD
2020-12-29 2020-12-28 PS Planned sale

Turtle Cameron

See Remarks

Officer
10,937 -34.1%
69.34
758,329 USD
10,937 -34.1% 69.34 758,329 USD
2020-12-23 2020-12-21 S Sale

SCHELLER RICHARD H

See Remarks

Executive Director
45,473 -49.8%
65.48
2,977,699 USD
45,473 -49.8% 65.48 2,977,699 USD
2020-12-23 2020-12-21 S Sale

SCHELLER RICHARD H

See Remarks

Executive Director
14,928 -14.0%
64.81
967,437 USD
14,928 -14.0% 64.81 967,437 USD
2020-12-21 2020-12-18 S Sale

SCHELLER RICHARD H

See Remarks

Executive Director
2,895 -2.7%
65.78
190,432 USD
2,895 -2.7% 65.78 190,432 USD
2020-12-21 2020-12-18 S Sale

SCHELLER RICHARD H

See Remarks

Executive Director
27,105 -19.9%
64.99
1,761,589 USD
27,105 -19.9% 64.99 1,761,589 USD
2020-12-17 2020-12-15 S Sale

SCHELLER RICHARD H

See Remarks

Executive Director
19,352 -12.4%
60.73
1,175,303 USD
19,352 -12.4% 60.73 1,175,303 USD
2020-12-17 2020-12-15 S Sale

SCHELLER RICHARD H

See Remarks

Executive Director
12,091 -7.2%
59.81
723,114 USD
12,091 -7.2% 59.81 723,114 USD
2020-12-02 2020-12-01 PS Planned sale

HENDERSON MICHAEL THOMAS

Chief Business Officer

Officer
6,972 -2.5%
51.69
360,408 USD
6,972 -2.5% 51.69 360,408 USD
2020-12-02 2020-12-01 PS Planned sale

HENDERSON MICHAEL THOMAS

Chief Business Officer

Officer
3,028 -1.1%
51.12
154,796 USD
3,028 -1.1% 51.12 154,796 USD
2020-11-25 2020-11-25 PS Planned sale

Turtle Cameron

See Remarks

Officer
742 -5.6%
47.23
35,044 USD
742 -5.6% 47.23 35,044 USD
2020-11-25 2020-11-24 PS Planned sale

Turtle Cameron

See Remarks

Officer
4,258 -25.3%
47.00
200,137 USD
4,258 -25.3% 47.00 200,137 USD
2020-11-18 2020-11-16 PS Planned sale

HENDERSON MICHAEL THOMAS

Chief Business Officer

Officer
10,000 -3.6%
45.00
450,000 USD
10,000 -3.6% 45.00 450,000 USD
2020-11-17 2020-11-13 S Sale

MCCORMICK FRANK

Chairman of Oncology

Officer
10,069 -0.8%
43.57
438,688 USD
10,069 -0.8% 43.57 438,688 USD
2020-11-17 2020-11-13 S Sale

MCCORMICK FRANK

Chairman of Oncology

Officer
58,299 -4.6%
42.91
2,501,546 USD
58,299 -4.6% 42.91 2,501,546 USD
2020-11-17 2020-11-13 S Sale

MCCORMICK FRANK

Chairman of Oncology

Officer
31,632 -2.4%
42.22
1,335,535 USD
31,632 -2.4% 42.22 1,335,535 USD
2020-11-09 2020-11-05 PS Planned sale

Turtle Cameron

See Remarks

Officer
2,500 -16.6%
42.05
105,125 USD
2,500 -16.6% 42.05 105,125 USD
2020-11-03 2020-11-02 PS Planned sale

HENDERSON MICHAEL THOMAS

Chief Business Officer

Officer
500 -0.2%
38.92
19,458 USD
500 -0.2% 38.92 19,458 USD
2020-11-03 2020-11-02 PS Planned sale

HENDERSON MICHAEL THOMAS

Chief Business Officer

Officer
9,500 -3.4%
38.33
364,100 USD
9,500 -3.4% 38.33 364,100 USD
2020-10-19 2020-10-16 PS Planned sale

HOMCY CHARLES J

Chairman of Pharmaceuticals

Executive Director
10,256 -0.8%
41.00
420,496 USD
10,256 -0.8% 41.00 420,496 USD
2020-10-05 2020-10-01 PS Planned sale

HENDERSON MICHAEL THOMAS

Chief Business Officer

Officer
5,505 -2.0%
39.28
216,249 USD
5,505 -2.0% 39.28 216,249 USD
2020-10-05 2020-10-01 PS Planned sale

HENDERSON MICHAEL THOMAS

Chief Business Officer

Officer
4,495 -1.6%
38.29
172,093 USD
4,495 -1.6% 38.29 172,093 USD
2020-10-02 2020-09-30 PS Planned sale

Turtle Cameron

See Remarks

Officer
2,058 -14.1%
38.24
78,707 USD
2,058 -14.1% 38.24 78,707 USD
2020-10-02 2020-09-30 PS Planned sale

Turtle Cameron

See Remarks

Officer
12,442 -46.0%
37.59
467,751 USD
12,442 -46.0% 37.59 467,751 USD
2020-10-01 2020-09-30 PS Planned sale

HOMCY CHARLES J

Chairman of Pharmaceuticals

Executive Director
10,000 -0.8%
38.00
380,000 USD
10,000 -0.8% 38.00 380,000 USD
2020-09-29 2020-09-29 PS Planned sale

HOMCY CHARLES J

Chairman of Pharmaceuticals

Executive Director
18,200 -1.5%
37.50
682,500 USD
18,200 -1.5% 37.50 682,500 USD